Inhibition of Fructosamine Oxidase in Diabetic Nephropathy (INFO-Renal) Study

Phase 2

Completed

• Conditions: Patients with type 2 diabetic nephropathy; Metabolic and Endocrine - Diabetes; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12612000959875
• Lead Sponsor: Protemix Corporation, Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-09-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Men and women between 30 to 70 years of age with poor blood glucose control, retinopathy and nephropathy resulting from Type 2 diabetes mellitus.

Exclusion Criteria

Healthy volunteers excluded, and those with with poor blood glucose control, retinopathy and nephropathy resulting from Type 2 diabetes mellitus, but outside of the age range above

Study & Design

• Study Type: Interventional
• Study Design: Not specified